Medicine
 |
|
22 april 2019 19:02:11 |
| Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study (Nature Medicine) |
|
Tweet |
| 90 viewsCategory: Medicine |
 Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study (Nature Medicine)A safe and potent anti-CD19 CAR T cell therapy (Nature Medicine) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
